Approval · Notice of Compliance 10084 · 2009
CELSENTRI: Notice of Compliance 10084
Issued March 11, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10084
- Date
- March 11, 2009
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph; addition of 48 week data
- Therapeutic class
- Ccr5 antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CELSENTRI | Not yet assigned | — |